Last reviewed · How we verify

Guaiastil — Competitive Intelligence Brief

Guaiastil (GUAIACOL) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: guaiacol. Area: Infectious Disease.

marketed guaiacol Carbonic anhydrase 2 Infectious Disease Small molecule Live · refreshed every 30 min

Target snapshot

Guaiastil (GUAIACOL).

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Guaiastil TARGET GUAIACOL marketed guaiacol Carbonic anhydrase 2
Tri-Luma HYDROQUINONE Galderma Labs Lp marketed Melanin Synthesis Inhibitor [EPC] Carbonic anhydrase 2 2002-01-01
Trusopt DORZOLAMIDE Merck & Co. marketed Carbonic Anhydrase Inhibitor Carbonic anhydrase 2 1994-01-01
Ammonul SODIUM BENZOATE marketed sodium benzoate Carbonic anhydrase 2 1987-01-01
Lithostat ACETOHYDROXAMIC ACID Mission Pharma marketed Urease Inhibitor [EPC] Carbonic anhydrase 2 1983-01-01
Zinacef CEFUROXIME GSK marketed Cephalosporin Antibacterial Carbonic anhydrase 2 1983-01-01
Cinobac CINOXACIN Eli Lilly marketed cinoxacin Carbonic anhydrase 2 1980-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (guaiacol class)

  1. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Guaiastil — Competitive Intelligence Brief. https://druglandscape.com/ci/guaiacol. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: